Drug
Nemonoxacin clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 3
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
11 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 3
- Phase 3
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
TaiGen Biotechnology Co., Ltd. (8) · Zhejiang Medicine Co., Ltd. (2) · R-Pharm (1)
Studies
Open first, then newest update. How each study uses nemonoxacin is read from its arms, and is right about nine times in ten.
Testing it · 11
- Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium ChlorideCompletedPhase 2TaiGen Biotechnology Co., Ltd.NCT01944774Written as Nemonoxacin 500 mg
- Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot InfectionsCompletedPhase 2TaiGen Biotechnology Co., Ltd.NCT00685698Written as TG-873870 (Nemonoxacin)
- Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired PneumoniaCompletedPhase 3R-PharmNCT03551210Written as Nemonoxacin
- Oral Nemonoxacin in Treating Elderly Patients With CAPCompletedPhase 4TaiGen Biotechnology Co., Ltd.NCT05133752Written as Nemonoxacin
- A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAPCompletedPhase 3TaiGen Biotechnology Co., Ltd.NCT02205112Written as Nemonoxacin
- Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal FunctionStatus unknownPhase 1Zhejiang Medicine Co., Ltd.NCT02840812Written as Nemonoxacin
- Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic FunctionCompletedPhase 1Zhejiang Medicine Co., Ltd.NCT02604498Written as Nemonoxacin
- A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic CharacteristicsCompletedPhase 1TaiGen Biotechnology Co., Ltd.NCT03362853Written as Nemonoxacin 500Mg Capsule
- Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAPCompletedPhase 3TaiGen Biotechnology Co., Ltd.NCT01529476Written as Nemonoxacin
- Clinical Study on Oral Nemonoxacin Malate CapsulesCompletedPhase 1TaiGen Biotechnology Co., Ltd.NCT01395108Written as Nemonoxacin
- Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired PneumoniaCompletedPhase 2TaiGen Biotechnology Co., Ltd.NCT00434291Written as TG-873870(Nemonoxacin)
Codes
What other systems call nemonoxacin · ClinicalTrials.gg INT005490
- MeSH (NLM) C543520nemonoxacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) P94L0PVO94NEMONOXACINConfirmed FDA, NLM, Wikidata
- Wikidata Q15425793nemonoxacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C174838NemonoxacinOne source FDA
- DrugBank DB06600One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C543520 | nemonoxacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | P94L0PVO94 | NEMONOXACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15425793 | nemonoxacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C174838 | Nemonoxacin | One source FDA |
| DrugBank | DB06600 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.